Similar articles for PMID: 33813413

Year	Number of Results
1994	2
1995	1
1996	2
1997	3
1998	3
1999	6
2000	4
2001	2
2002	5
2003	4
2004	4
2005	2
2006	2
2007	1
2008	3
2009	3
2010	6
2011	6
2012	5
2013	2
2014	5
2015	11
2016	4
2017	5
2018	5
2019	5
2020	3
2021	1

1

Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy.

Svaton M, Blazek J, Krakorova G, Pesek M, Buresova M, Teufelova Z, Vodicka J, Hurdalkova K, Barinova M, Topolcan O. Svaton M, et al. Anticancer Res. 2021 Apr;41(4):2053-2058. doi: 10.21873/anticanres.14974. Anticancer Res. 2021. PMID: 33813413

2

High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.

Duan X, Cui Y, Li H, Shi G, Wu B, Liu M, Chang D, Wang T, Kong Y. Duan X, et al. Indian J Cancer. 2015 Dec;52 Suppl 3:E158-63. doi: 10.4103/0019-509X.186564. Indian J Cancer. 2015. PMID: 27453414 Free article.

3

CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.

Sone K, Oguri T, Nakao M, Kagawa Y, Kurowaka R, Furuta H, Fukuda S, Uemura T, Takakuwa O, Kanemitsu Y, Ohkubo H, Takemura M, Maeno K, Ito Y, Sato H, Muramatsu H, Niimi A. Sone K, et al. Anticancer Res. 2017 Feb;37(2):935-939. doi: 10.21873/anticanres.11402. Anticancer Res. 2017. PMID: 28179355

4

CEA, CYFRA21-1 and SCC in non-small cell lung cancer.

Moro D, Villemain D, Vuillez JP, Delord CA, Brambilla C. Moro D, et al. Lung Cancer. 1995 Oct;13(2):169-76. doi: 10.1016/0169-5002(95)00485-8. Lung Cancer. 1995. PMID: 8581396

5

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Ardizzoni A, et al. Cancer. 2006 Dec 15;107(12):2842-9. doi: 10.1002/cncr.22330. Cancer. 2006. PMID: 17103443 Free article.

6

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib.

Chen F, Luo X, Zhang J, Lu Y, Luo R. Chen F, et al. Med Oncol. 2010 Sep;27(3):950-7. doi: 10.1007/s12032-009-9315-8. Epub 2009 Oct 15. Med Oncol. 2010. PMID: 19830603

7

Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.

Kulpa J, Wójcik E, Reinfuss M, Kołodziejski L. Kulpa J, et al. Clin Chem. 2002 Nov;48(11):1931-7. Clin Chem. 2002. PMID: 12406978

8

Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score.

Blankenburg F, Hatz R, Nagel D, Ankerst D, Reinmiedl J, Gruber C, Seidel D, Stieber P. Blankenburg F, et al. Tumour Biol. 2008;29(4):272-7. doi: 10.1159/000152945. Epub 2008 Sep 9. Tumour Biol. 2008. PMID: 18781099

9

The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.

Ma S, Shen L, Qian N, Chen K. Ma S, et al. Cancer Biomark. 2011-2012;10(3-4):155-62. doi: 10.3233/CBM-2012-0246. Cancer Biomark. 2011. PMID: 22674301

10

Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.

Fiala O, Pesek M, Finek J, Benesova L, Minarik M, Bortlicek Z, Topolcan O. Fiala O, et al. Anticancer Res. 2014 Jun;34(6):3205-10. Anticancer Res. 2014. PMID: 24922695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed